Results 121 to 130 of about 6,295,269 (238)

Inconsistencies in recommendations for the preventive management of pre-eclampsia and quality assessment of international guidelines: a systematic review

BMC Pregnancy and Childbirth
Background Recommendations for the preventive management of pre-eclampsia remain inconsistent across existing guidelines, which may adversely affect clinical decision-making.
Sha Diao, Yuan Feng, Nan Yang, Panda Qiu, Puwen Zhang, Hailong Li, Dan Liu, Linan Zeng, Rong Zhou, Lingli Zhang   +9 more
doaj   +1 more source

Is the AGREE II framework the appropriate tool to evaluate global urolithiasis guidelines? [PDF]

Transl Androl Urol, 2023
Ramakrishnan VM, Yim K, Wollin DA.
europepmc   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Inter-rater reliability for the AGREE II domains.

, 2018
Inter-rater reliability for the AGREE II domains.
Jihad Abdelgadir (843923), Edson A. Miguel (5587379), Oscar Obiga (5587373), Catherine Staton (843919), Nelly Weledji (5587370), Henry Rice (2552317), Joao Ricardo Nickenig Vissoci (3326871), Taylor Nelp (5587367), Carolina M. Vissoci (5587382), Michael Haglund (3967550), Roselyn Appenteng (5587364), Emily Smith (3125130), Francis M. Sakita (5587376)   +12 more
core   +1 more source

Systematic review, methodological appraisal, and recommendation mapping of clinical practice guidelines for managing patients with Stevens-Johnson syndrome and toxic epidermal necrolysis

Journal of Dermatological Treatment
Purpose The Appraisal of Guidelines for Research and Evaluation II Instrument (AGREE II) was developed to enhance the methodological rigor of clinical practice guidelines (CPGs), aiming to generate trustworthy recommendations for various clinical ...
Mohammed AlFada, Hend Alotaibi, Sahar Alsharif, Ahmad Hecham Alani, Andrea Andrade-Miranda, Camila Montesinos Guevara, Yaolong Chen, Ruobing Lei, Jorge Acosta-Reyes, Pamela Velásquez-Salazar, Ahmed El-Malky, Yasser S. Amer   +11 more
doaj   +1 more source

Assessment of the AAOS guidelines using the AGREE II instrument: An update. [PDF]

J Orthop, 2023
Lilova R, Dubin J, Hameed D, Pettijohn WA, Bains SS, Reich J, Moore MC, Delanois RE.   +7 more
europepmc   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source

AGREE II scaled domain scores of CPGs for SSI prevention.

, 2018
AGREE II scaled domain scores of CPGs for SSI prevention.
Brigid M. Gillespie (5746136), Shelley Roberts (4239160), Claudia Bull (5746139), Wendy Chaboyer (4239157), Rachel Walker (5746142), Frances Lin (4761384)   +5 more
core   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

Molecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur, Joel Rodrigues Vitória, Manuel Saiselet, Ligia Craciun, Denis Larsimont, Anne Lefort, Frédérick Libert, Carine Maenhaut, Sabine Costagliola, Maxime Tarabichi, Mirian Romitti, Vincent Detours   +11 more
wiley   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park, Kyongman An, Gyeonghwa Kim, Soo‐Nyun Choi, Hong‐Ki Lee, Keun Hur, Kyu‐Shik Jeong   +6 more
wiley   +1 more source